.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Novartis
Moodys
AstraZeneca
Citi
Express Scripts
Colorcon
McKesson
Julphar
Merck

Generated: June 25, 2017

DrugPatentWatch Database Preview

Loxapine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for loxapine hydrochloride and what is the scope of loxapine hydrochloride patent protection?

Loxapine hydrochloride
is the generic ingredient in two branded drugs marketed by Actavis Labs Ut Inc and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for loxapine hydrochloride.

Summary for Generic Name: loxapine hydrochloride

Tradenames:2
Patents:1
Applicants:1
NDAs:2
Drug Master File Entries: see list8
Bulk Api Vendors: see list4
Clinical Trials: see list2,265
Patent Applications: see list482
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:loxapine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc
LOXITANE C
loxapine hydrochloride
CONCENTRATE;ORAL017658-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Actavis Labs Ut Inc
LOXITANE IM
loxapine hydrochloride
INJECTABLE;INJECTION018039-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: loxapine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actavis Labs Ut Inc
LOXITANE IM
loxapine hydrochloride
INJECTABLE;INJECTION018039-001Approved Prior to Jan 1, 19823,546,226► Subscribe
Actavis Labs Ut Inc
LOXITANE C
loxapine hydrochloride
CONCENTRATE;ORAL017658-001Approved Prior to Jan 1, 19824,049,809► Subscribe
Actavis Labs Ut Inc
LOXITANE C
loxapine hydrochloride
CONCENTRATE;ORAL017658-001Approved Prior to Jan 1, 19823,546,226► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
US Department of Justice
Teva
Colorcon
Chubb
Dow
Farmers Insurance
Accenture
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot